Selected Publications

Academic Article

Year Title Altmetric
2022 Retraction: CXCR6 Induces Prostate Cancer Progression by the AKT/Mammalian Target of Rapamycin Signaling Pathway (Cancer Research (2022) 82 (3406) DOI: 10.1158/0008-5472.CAN-08-2780)Cancer Research.  82:3406. 2022
2022 Retraction: Characterization of Phosphoglycerate Kinase-1 Expression of Stromal Cells Derived from Tumor Microenvironment in Prostate Cancer Progression (Cancer Research (2022) 82 (3405) DOI: 10.1158/0008-5472.CAN-09-2863)Cancer Research.  82:3405. 2022
2022 Erratum: Withdrawal: The role of CXCR7/RDC1 as a chemokine receptor for CXCL12/SDF-1 in prostate cancer (Journal of Biological Chemistry (2008) 283(7) (4283–4294), (S0021925820697381), (10.1074/jbc.M707465200))Journal of Biological Chemistry.  298. 2022
2021 Monitoring Spontaneous Quiescence and Asynchronous Proliferation-Quiescence Decisions in Prostate Cancer CellsFrontiers in Cell and Developmental Biology.  9. 2021
2021 Erratum: CXCL12γ promotes metastatic castration-resistant prostate cancer by inducing cancer stem cell and neuroendocrine phenotypes (Cancer Research (2018) 78 (2026–2039) DOI: 10.1158/0008-5472.CAN-17-2332)Cancer Research.  81:5777. 2021
2021 Use of FVB Myc-CaP cells as an immune competent, androgen receptor positive, mouse model of prostate cancer bone metastasisJournal of Bone Oncology.  30. 2021
2021 Dura promotes metastatic potential in prostate cancer through the CXCR2 pathwayJournal of Neuro-Oncology.  153:33-42. 2021
2021 Retraction notice to <“Diverse signaling pathways through the SDF-1/CXCR4 chemokine axis in prostate cancer cell lines leads to altered patterns of cytokine secretion and angiogenesis”> <[Cellular Signaling 17/12 (2005) 1578–1592]> (Cellular Signalling (2005) 17(12) (1578–1592), (S0898656805000677), (10.1016/j.cellsig.2005.03.022))Cellular Signalling.  80. 2021
2021 Retraction: A glycolytic mechanism regulating an angiogenic switch in prostate cancer (Cancer Research (2007) 67 (149-159) DOI: 10.1158/0008-5472.CAN-06-2971)Cancer Research.  81:1623. 2021
2021 Abscisic acid regulates dormancy of prostate cancer disseminated tumor cells in the bone marrowNeoplasia.  23:102-111. 2021
2020 CXCL12γ induces human prostate and mammary gland development 2020
2020 Adrenergic Blockade Promotes Maintenance of Dormancy in Prostate Cancer Through Upregulation of GAS6Translational Oncology.  13. 2020
2020 Bone microenvironment signaling of cancer stem cells as a therapeutic target in metastatic prostate cancer 2020
2020 Wnt Signaling Drives Prostate Cancer Bone Metastatic Tropism and InvasionTranslational Oncology.  13. 2020
2020 The assessment of stress, depression, and inflammation as a collective risk factor for periodontal diseases: a systematic reviewClinical Oral Investigations.  24. 2020
2019 Anticancer polymers designed for killing dormant prostate cancer cellsScientific Reports.  9. 2019
2019 Author Correction: Anticancer polymers designed for killing dormant prostate cancer cells (Scientific Reports, (2019), 9, 1, (1096), 10.1038/s41598-018-36608-5)Scientific Reports.  9. 2019
2019 Primary prostate cancer educates bone stroma through exosomal pyruvate kinase M2 to promote bone metastasisJournal of Experimental Medicine.  216:2883-2899. 2019
2019 Detection and isolation of disseminated tumor cells in bone marrow of patients with clinically localized prostate cancer 2019
2019 Circulating Tumor Cell–Based Molecular Classifier for Predicting Resistance to Abiraterone and Enzalutamide in Metastatic Castration-Resistant Prostate CancerNeoplasia.  21:802-809. 2019
2019 Parallels between hematopoietic stem cell and prostate cancer disseminated tumor cell regulationBone.  119:82-86. 2019
2019 Determining competitive potential of bone metastatic cancer cells in the murine hematopoietic stem cell nicheMethods in Molecular Biology.  2002:141-150. 2019
2018 Dural cells release factors which promote cancer cell malignancy and induce immunosuppressive markers in bone marrow myeloid cellsNeurosurgery.  83:1306-1316. 2018
2018 Integrin alpha V beta 3 targeted dendrimer-rapamycin conjugate reduces fibroblast-mediated prostate tumor progression and metastasisJournal of Cellular Biochemistry.  119:8074-8083. 2018
2018 CXCL12g promotes metastatic castration-resistant prostate cancer by inducing cancer stem cell and neuroendocrine phenotypesCancer Research.  78:2026-2039. 2018
2018 Multigene profiling of CTCs in mCRPC identifies a clinically relevant prognostic signatureMolecular Cancer Research.  16:643-654. 2018
2018 Reduction of two histone marks, H3k9me3 and H3k27me3 by epidrug induces neuroendocrine differentiation in prostate cancerJournal of Cellular Biochemistry.  119:3697-3705. 2018
2018 Periodontal Treatment in Cancer Patients: an Interdisciplinary ApproachCurrent Oral Health Reports.  5:7-12. 2018
2017 Sympathetic signaling reactivates quiescent disseminated prostate cancer cells in the bone marrowMolecular Cancer Research.  15:1644-1655. 2017
2017 A comparative analysis of the Su-pung-er and Bayne testimonies related to the Franklin expeditionPolar Record.  53:561-579. 2017
2017 Biochemical Changes in the Niche Following Tumor Cell InvasionJournal of Cellular Biochemistry.  118:1956-1964. 2017
2017 Mer Tyrosine Kinase Regulates Disseminated Prostate Cancer Cellular DormancyJournal of Cellular Biochemistry.  118:891-902. 2017
2017 A critical assessment of the oral condition of the crew of the franklin expeditionArctic.  70:25-36. 2017
2017 Clinical assessment of urinary tract damage during sustained-release estrogen supplementation in mice 2017
2017 Correction: The marrow niche controls the cancer stem cell phenotype of disseminated prostate cancer [Oncotarget., 7, (2016) (41217-41232)] doi: 10.18632/oncotarget.9251Oncotarget.  8:38075. 2017
2017 Dental students', alumni, and dentists' perspectives on leadership: Impact of the scholars program in dental leadershipJournal of Dental Education.  81:44-53. 2017
2016 Growth Arrest-Specific 6 (GAS6) Promotes Prostate Cancer Survival by G1 Arrest/S Phase Delay and Inhibition of Apoptosis During Chemotherapy in Bone MarrowJournal of Cellular Biochemistry.  2815-2824. 2016
2016 Axl is required for TGF-β2-induced dormancy of prostate cancer cells in the bone marrowScientific Reports.  6. 2016
2016 DNMT1 Regulates Epithelial-Mesenchymal Transition and Cancer Stem Cells, Which Promotes Prostate Cancer MetastasisNeoplasia.  18:553-566. 2016
2016 The role of hematopoietic stem cell niche in prostate cancer bone metastasisJournal of Bone Oncology.  5:117-120. 2016
2016 The marrow niche controls the cancer stem cell phenotype of disseminated prostate cancerOncotarget.  7:41217-41232. 2016
2016 Endogenous GAS6 and Mer receptor signaling regulate prostate cancer stem cells in bone marrowOncotarget.  7:25698-25711. 2016
2016 Mechanistic Support for Combined MET and AR Blockade in Castration-Resistant Prostate CancerNeoplasia.  18:1-9. 2016
2015 Bone: Elucidating which cell erythropoietin targets in boneNature Reviews Endocrinology.  11:263-264. 2015
2015 Tissue engineering a surrogate niche for metastatic cancer cellsClinical materials.  51:313-319. 2015
2015 Erythropoietin promotes bone formation through EphrinB2/EphB4 signaling 2015
2015 Annexin 2-CXCL12 interactions regulate metastatic cell targeting and growth in the bone marrowMolecular Cancer Research.  13:197-207. 2015
2015 Bone marrow as a metastatic niche for disseminated tumor cells from solid tumors.BoneKEy Reports.  4:689. 2015
2015 The Role of Osteoclasts in Early Dissemination of Prostate Cancer Tumor Cells.Journal of cancer stem cell research.  3. 2015
2015 The bone marrow endosteal niche: how far from the surface?Journal of Cellular Biochemistry.  116:6-11. 2015
2014 Endothelial interleukin-6 defines the tumorigenic potential of primary human cancer stem cellsStem Cells.  32:2845-2857. 2014
2014 HSCs and niche relations marked by CD166Blood.  124:471-472. 2014
2014 Molecular pathways: Niches in metastatic dormancyClinical Cancer Research.  20:3384-3389. 2014
2014 Dentists' leadership-related educational experiences, attitudes, and past and current behaviorJournal of Dental Education.  78:876-885. 2014
2014 Expanding the scholarship on leadership training in dental educationJournal of Dental Education.  78:811-812. 2014
2014 Human and murine very small embryonic-like cells represent multipotent tissue progenitors, in vitro and in vivoStem Cells and Development.  23:689-701. 2014
2014 Human bone marrow mesenchymal progenitors: Perspectives on an optimized in vitro manipulationFrontiers in Cell and Developmental Biology.  2. 2014
2014 A novel method for monitoring tumor proliferation in vivo using fluorescent dye DiD 2014
2014 Megakaryocytes are mechanically responsive and influence osteoblast proliferation and differentiationBone.  66:111-120. 2014
2014 Niche inheritance: A cooperative pathway to enhance cancer cell fitness though ecosystem engineeringJournal of Cellular Biochemistry.  115:1478-1485. 2014
2014 TAM macrophages promote growth and metastasis within the cancer ecosystemOncoImmunology.  3. 2014
2013 Developing the next generation of leaders in oral healthJournal of Dental Education.  77:1508-1514. 2013
2013 Erythropoietin supports the survival of prostate cancer, but not growth and bone metastasisJournal of Cellular Biochemistry.  114:2471-2478. 2013
2013 The cancer diaspora: Metastasis beyond the seed and soil hypothesisClinical Cancer Research.  19:5849-5855. 2013
2013 The effect of low and high plasma levels of insulin-like growth factor-1 (IGF-1) on the morphology of major organs: Studies of laron dwarf and bovine growth hormone transgenic (bGHTg) mice 2013
2013 TBK1 regulates prostate cancer dormancy through mTOR inhibitionNeoplasia.  15:1064-1074. 2013
2013 Recruitment of mesenchymal stem cells into prostate tumours promotes metastasisNature Communications.  4. 2013
2013 Cancer stem cells and their role in metastasisPharmacology and Therapeutics.  138:285-293. 2013
2013 GAS6 Receptor Status Is Associated with Dormancy and Bone Metastatic Tumor FormationPLoS One.  8. 2013
2013 Human very small embryonic-like cells generate skeletal structures, in vivoStem Cells and Development.  22:622-630. 2013
2013 Impact of proteoglycan-4 and parathyroid hormone on articular cartilageJournal of Orthopaedic Research.  31:183-190. 2013
2013 An HLA-DRB1-coded signal transduction ligand facilitates inflammatory arthritis: A new mechanism of autoimmunityJournal of Immunology.  190:48-57. 2013
2013 Dentists' leadership-related perceptions, values, experiences and behavior results of a national surveyJournal of the American Dental Association.  144:1397-1405. 2013
2013 Detection and isolation of human disseminated tumor cells in the murine bone marrow stem cell nicheMethods in Molecular Biology.  1035:207-215. 2013
2013 The effects of zoledronic acid in the bone and vasculature support of hematopoietic stem cell nichesJournal of Cellular Biochemistry.  114:67-78. 2013
2012 Molecular signature and in vivo behavior of bone marrow endosteal and subendosteal stromal cell populations and their relevance to hematopoiesisExperimental Cell Research.  318:2427-2437. 2012
2012 Erythropoietin modulates the structure of bone morphogenetic protein 2-engineered cranial bone 2012
2012 Getting blood from bone: An emerging understanding of the role that osteoblasts play in regulating hematopoietic stem cells within their nicheExperimental Hematology.  40:685-694. 2012
2012 Prostate cancer and parasitism of the bone hematopoietic stem cell nicheCritical Reviews in Eukaryotic Gene Expression.  22:131-148. 2012
2012 Hypoxia stabilizes GAS6/Axl signaling in metastatic prostate cancerMolecular Cancer Research.  10:703-712. 2012
2012 Where is leadership training being taught in U.S. dental schools?Journal of Dental Education.  76:713-720. 2012
2012 The prostate cancer bone marrow niche: More than just fertile soilAsian Journal of Andrology.  14:423-427. 2012
2012 Cancer Stem Cells and the Bone Marrow Microenvironment.BoneKEy Reports.  2012. 2012
2012 Disseminated prostate cancer cells can instruct hematopoietic stem and progenitor cells to regulate bone phenotypeMolecular Cancer Research.  10:282-292. 2012
2012 Annexin II interactions with the annexin II receptor enhance multiple myeloma cell adhesion and growth in the bone marrow microenvironmentBlood.  119:1888-1896. 2012
2012 Effects of erythropoietin on the bone microenvironmentGrowth Factors.  30:22-28. 2012
2012 Leadership training for oral health professionals: A call to actionJournal of Dental Education.  76:185-191. 2012
2012 Program design considerations for leadership training for dental and dental hygiene studentsJournal of Dental Education.  76:192-199. 2012
2012 Erythropoietin mediated bone formation is regulated by mTOR signalingJournal of Cellular Biochemistry.  113:220-228. 2012
2012 Prevalence of prostate cancer metastases after intravenous inoculation provides clues into the molecular basis of dormancy in the bone marrow microenvironmentNeoplasia.  14:429-439. 2012
2012 Structure and function of the solid tumor niche 2012
2011 An irradiation-altered bone marrow microenvironment impacts anabolic actions of PTH 2011
2011 Homing of cancer cells to the boneCancer Microenvironment.  4:221-235. 2011
2011 Mechanisms of cancer cell metastasis to the bone: A multistep processFuture Oncology.  7:1285-1297. 2011
2011 Proteoglycan 4, a novel immunomodulatory factor, regulates parathyroid hormone actions on hematopoietic cellsAmerican Journal of Pathology.  179:2431-2442. 2011
2011 Hematopoietic stem cell niche is a potential therapeutic target for bone metastatic tumorsClinical Cancer Research.  17:5553-5558. 2011
2011 Erratum: CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression (Cancer and Metastasis Reviews (2010) 29 (709-722) DOI: 10.1007/s10555-010-9256- x)Cancer and Metastasis Reviews.  30:269-270. 2011
2011 Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrowJournal of Clinical Investigation.  121:1298-1312. 2011
2011 Perceptions of business skill development by graduates of the University of Michigan Dental SchoolJournal of Dental Education.  75:505-517. 2011
2011 Mentoring of dental and dental hygiene faculty: A case studyJournal of Dental Education.  75:291-299. 2011
2011 Breast cancer stem cells are regulated by mesenchymal stem cells through cytokine networksCancer Research.  71:614-624. 2011
2011 Annexin-2 is a regulator of stromal cell-derived factor-1/CXCL12 function in the hematopoietic stem cell endosteal nicheExperimental Hematology.  39. 2011
2010 CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progressionCancer and Metastasis Reviews.  29:709-722. 2010
2010 Prospective identification and skeletal localization of cells capable of multilineage differentiation in vivoStem Cells and Development.  19:1557-1570. 2010
2010 Erythropoietin couples hematopoiesis with bone formationPLoS One.  5. 2010
2010 Dysfunctional niches as a root of hematopoietic malignancyCell Stem Cell.  6:399-400. 2010
2010 An in vivo model to study and manipulate the hematopoietic stem cell nicheBlood.  115:2592-2600. 2010
2010 GAS6/Mer axis regulates the homing and survival of the E2A/PBX1-positive B-cell precursor acute lymphoblastic leukemia in the bone marrow nicheExperimental Hematology.  38:132-140. 2010
2010 Phosphoglycerate kinase 1 a promoting enzyme for peritoneal dissemination in gastric cancerInternational Journal of Cancer.  126:1513-1520. 2010
2010 Characterization of phosphoglycerate kinase-1 expression of stromal cells derived from tumor microenvironment in prostate cancer progressionCancer Research.  70:471-480. 2010
2010 Adaptation of airline crew resource management principles to dentistryJournal of the American Dental Association.  141:1010-1018. 2010
2010 GAS6/AXL axis regulates prostate cancer invasion, proliferation, and survival in the bone marrow nicheNeoplasia.  12:116-127. 2010
2010 Probing the CXCR6/CXCL16 Axis: Targeting Prevention of Prostate Cancer Metastasis 2010
2009 Creation of a Scholars Program in Dental Leadership (SPDL) for dental and dental hygiene studentsJournal of Dental Education.  73:1139-1143. 2009
2009 Expression of PGK1 by prostate cancer cells induces bone formationMolecular Cancer Research.  7:1595-1604. 2009
2009 Hedgehog Signaling Is Dispensable for Adult Hematopoietic Stem Cell FunctionCell Stem Cell.  4:548-558. 2009
2009 Microfluidic system for formation of PC-3 prostate cancer co-culture spheroidsClinical materials.  30:3020-3027. 2009
2009 Ability of dental students to deliver oxygen in a medical emergencyJournal of Dental Education.  73:499-508. 2009
2009 Innovative mouse models for metastatic diseaseDrug Discovery Today: Disease Models.  6:27-31. 2009
2008 CXCR6 induces prostate cancer progression by the AKT/mammalian target of rapamycin signaling pathwayCancer Research.  68:10367-10376. 2008
2008 CD26/dipeptidyl peptidase IV regulates prostate cancer metastasis by degrading SDF-1/CXCL12Clinical and Experimental Metastasis.  25:765-776. 2008
2008 Advancing treatment for metastatic bone cancer: Consensus recommendations from the second cambridge conferenceClinical Cancer Research.  14:6387-6395. 2008
2008 Annexin II/annexin II receptor axis regulates adhesion, migration, homing, and growth of prostate cancerJournal of Cellular Biochemistry.  105:370-380. 2008
2008 Hematopoietic stem cells regulate mesenchymal stromal cell induction into osteoblasts thereby participating in the formation of the stem cell nicheStem Cells.  26:2042-2051. 2008
2008 Stromal-derived factor-lα (CXCL 12) leveis increase in periodontal diseaseJournal of Periodontology.  79:845-853. 2008
2008 CXCL16 functions as a novel chemotactic factor for prostate cancer cells in vitroMolecular Cancer Research.  6:546-554. 2008
2008 The role of CXCR7/RDC1 as a chemokine receptor for CXCL12/SDF-1 in prostate cancerJournal of Biological Chemistry.  283:4283-4294. 2008
2008 An in vivo mouse model for human prostate cancer metastasisNeoplasia.  10:371-379. 2008
2008 The bone marrow niche: Habitat to hematopoietic and mesenchymal stem cells, and unwitting host to molecular parasitesLeukemia.  22:941-950. 2008
2007 New trends in the treatment of bone metastasisJournal of Cellular Biochemistry.  102:1095-1102. 2007
2007 The evolving biology and treatment of prostate cancerJournal of Clinical Investigation.  117:2351-2361. 2007
2007 Annexin II expressed by osteoblasts and endothelial cells regulates stem cell adhesion, homing, and engraftment following transplantationBlood.  110:82-90. 2007
2007 Osteoblasts support B-lymphocyte commitment and differentiation from hematopoietic stem cellsBlood.  109:3706-3712. 2007
2007 Lead exposure and periodontitis in US adultsJournal of Periodontal Research.  42:45-52. 2007
2007 A glycolytic mechanism regulating an angiogenic switch in prostate cancerCancer Research.  67:149-159. 2007
2007 Expression and activation of αvβ3 integrins by SDF-1/CXC12 increases the aggressiveness of prostate cancer cells 2007
2006 The pivotal role of CXCL12 (SDF-1)/CXCR4 axis in bone metastasisCancer and Metastasis Reviews.  25:573-587. 2006
2006 The role of sialomucin CD164 (MGC-24v or endolyn) in prostate cancer metastasisBMC Cancer.  6. 2006
2006 Ablation of proliferating marrow with 5-fluorouracil allows partial purification of mesenchymal stem cellsStem Cells.  24:1573-1582. 2006
2006 Regulation of SDF-1 (CXCL12) production by osteoblasts; a possible mechanism for stem cell homingBone.  38:497-508. 2006
2005 Cell-to-cell contact is critical for the survival of hematopoietic progenitor cells on osteoblastsCytokine.  32:155-162. 2005
2005 Cells of the osteoclast lineage as mediators of the anabolic actions of parathyroid hormone in bone 2005
2005 The bisphosphonate YM529 inhibits osteolytic and osteoblastic changes and CXCR-4-induced invasion in prostate cancerCancer Research.  65:8818-8825. 2005
2005 Clusterin inhibits apoptosis by interacting with activated BaxNature Cell Biology.  7:909-915. 2005
2005 Blood and bone: Two tissues whose fates are intertwined to create the hematopoietic stem-cell nicheBlood.  105:2631-2639. 2005
2005 Skeletal localization and neutralization of the SDF-1(CXCL12)/CXCR4 axis blocks prostate cancer metastasis and growth in osseous sites in vivoJournal of Bone and Mineral Research.  20:318-329. 2005
2005 Diverse signaling pathways through the SDF-1/CXCR4 chemokine axis in prostate cancer cell lines leads to altered patterns of cytokine secretion and angiogenesisCellular Signalling.  17:1578-1592. 2005
2005 Expression of the chemokine receptor CCR7 in prostate cancer presenting with generalized lymphadenopathy: Report of a case, review of the literature, and analysis of chemokine receptor expressionUrologic Oncology: seminars and original investigations.  23:261-267. 2005
2005 The role of osteoblasts in regulating hematopoietic stem cell activity and tumor metastasisBrazilian Journal of Medical and Biological Research.  38:1449-1454. 2005
2004 Inhibition of breast cancer metastasis by selective synthetic polypeptide against CXCR4Cancer Research.  64:4302-4308. 2004
2004 N-linked sialyated sugar receptors support haematopoietic cell-osteoblast adhesionsBritish Journal of Haematology.  124:534-546. 2004
2004 Vascular Endothelial Growth Factor Contributes to the Prostate Cancer-Induced Osteoblast Differentiation Mediated by Bone Morphogenetic ProteinCancer Research.  64:994-999. 2004
2004 Cancer cells homing to bone: the significance of chemotaxis and cell adhesion.Cancer Treatment and Research.  118:291-309. 2004
2004 Detection and isolation of circulating tumor cells in urologic cancers: A reviewNeoplasia.  6:302-309. 2004
2003 Expression of CXCR4 and CXCL12 (SDF-1) in human prostate cancers (PCa) in vivoJournal of Cellular Biochemistry.  89:462-473. 2003
2002 G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4.Nature Immunology.  3:687-694. 2002
2002 Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to boneCancer Research.  62:1832-1837. 2002
2001 Hepatocyte growth factor is secreted by osteoblasts and cooperatively permits the survival of haematopoietic progenitorsBritish Journal of Haematology.  112:438-448. 2001
2001 Prostate carcinoma skeletal metastases: Cross-talk between tumor and boneCancer and Metastasis Reviews.  20:333-349. 2001
2000 Secretory products from PC-3 and MCF-7 tumor cell lines upregulate osteopontin in MC3T3,-E1 cellsJournal of Cellular Biochemistry.  78:607-616. 2000
2000 Bone marrow accessory cells regulate human bone precursor cell developmentExperimental Hematology.  28:815-825. 2000
2000 Human osteoblast-like cells and osteosarcoma cell lines synthesize macrophage inhibitory protein 1α in response to interleukin 1β and tumour necrosis factor α stimulation in vitroBritish Journal of Haematology.  108:275-283. 2000
2000 Induction of the chemokine stromal-derived factor-1 following DNA damage improves human stem cell functionJournal of Clinical Investigation.  106:1331-1339. 2000
2000 The Hematopoietic Microenvironment: Osteoblasts and The Hematopoietic Microenvironment.Hematology.  4:421-426. 2000
1999 Osteoblasts and The Hematopoietic Microenvironment.Hematology.  4:421-426. 1999
1998 Protein Extracts of Dentin Affect Proliferation and Differentiation of Osteoprogenitor Cells in VitroJournal of Periodontology.  69:1247-1255. 1998
1998 The role of osteoblasts in the hematopoietic microenvironmentStem Cells.  16:7-15. 1998
1998 Ultrastructural aspects of cytomegalovirus-infected fibroblastic stromal cells of human bone marrowTissue and Cell.  30:398-406. 1998
1997 Human osteosarcomas inhibit hematopoietic colony formation: Partial reversal by antibody to transforming growth factor-β1Bone.  21:353-361. 1997
1997 Infection and replication of human cytomegalovirus in bone marrow stromal cells: Effects on the production of IL-6, MIP-1α, and TGF-β1Bone Marrow Transplantation.  19:471-480. 1997
1997 Augmented production of interleukin-6 by normal human osteoblasts in response to CD34+ hematopoietic bone marrow cells in vitroBlood.  89:1165-1172. 1997
1996 Human osteosarcoma cell lines MG-63 and SaOS-2 produce G-CSF and GM-CSF: Identification and partial characterization of cell-associated isoformsExperimental Hematology.  24:509-517. 1996
1996 Human osteoblasts support human hematopoietic progenitor cells in in vitro bone marrow culturesBlood.  87:518-524. 1996
1996 Comparison of benzimidazole nucleosides and ganciclovir on the in vitro proliferation and colony formation of human bone marrow progenitor cellsBritish Journal of Haematology.  93:273-279. 1996
1994 Protein tyrosine kinase p56-Lck regulates lymphocyte function-associated 1 adhesion molecule expression, granule exocytosis, and cytolytic effector function in a cloned T cell.Journal of Experimental Medicine.  180:1115-1127. 1994
1994 Human osteoblasts support hematopoiesis through the production of granulocyte colony-stimulating factorJournal of Experimental Medicine.  179:1677-1682. 1994
1994 Bcl-2 Inhibits T-Cell-mediated Cytolysis of a Leukemia Cell LineCancer Research.  54:4851-4854. 1994
1993 A strategy for constructing inducible expression plasmids for T-lymphocytes. 1993
1993 Evidence that protein tyrosine kinase p56-Lck regulates the activity of phosphatidylinositol-3'-kinase in interleukin-2-dependent T-cellsJournal of Biological Chemistry.  268:20031-20036. 1993
1993 Protooncogene-encoded protein kinases in interleukin-2 signal transductionSeminars in Immunology.  5:327-336. 1993
1992 Effects of interleukin-1 β and tumor necrosis factor-α on osteoblastic expression of osteocalcin and mineralized extracellular matrix in vitroInflammation.  16:587-601. 1992
1992 Gene transfer investigations of p56-LCK function in IL-2-dependent T-cell lines: Implications for mechanisms of IL-2-signal transductionCytokine.  4:441-453. 1992


Year Title Altmetric
2018 Minimal residual disease in prostate cancer.  47-53. 2018
2015 Hematopoietic stem cells and their niches.  44-63. 2015
2013 Skeletal Resident Stem Cells.  123-140. 2013

Education And Training

  • Doctor of Medical Sciences in Periodontics / Periodontology, Harvard University 1991
  • Doctor of Dental Medicine in Dentistry, University of Pennsylvania 1986
  • Bachelor of Science or Mathematics in Education, Villanova University 1982
  • Full Name

  • Russell Taichman